Literature DB >> 21163737

[Relation between paraoxonase activity, other HDL components and inflammatory state in hemodialyzed patients].

Ana I González1, Fernando Brites, Alicia Elbert, Leonardo Gómez-Rosso, Gabriela Berg, Regina Wikinski, Laura Schreier.   

Abstract

Advanced Chronic Renal Disease (CKD) is closely associated with a pro-inflammatory condition, with an increase in triglyceride-rich lipoproteins and decrease in HDL level. HDL contains antioxidant enzymes such as paraoxonase (PON), whose activity is diminished in CKD. The aim of our study was to evaluate the relationship between PON activity with HDL cholesterol, apo A1 and hs-CRP levels, which are known to be inflammatory markers in hemodialyzed patients. Forty-two patients were studied; age, median (range) = 50 (25-67) years old, gender M/F = 22/20, duration of hemodialysis = 4.4 ± 0.5 years, BMI: 23 ± 0.5 kg/m2. After a 12 h fast, a blood sample was obtained and classic components of lipid profile were determined, as well as apoproteins A1 and B, PON by means of its arylsterase activity and hs-CRP levels. On the basis of the latter, patients were divided into two groups: hs-CRP ≤ 1 (low risk, range: 0.1 to 1.0 mg/l) and > 1 mg/l (moderate and high risk, 1.1 to 10.7 mg/l). No difference was found in triglycerides, LDL cholesterol and apo B in the groups. Patients with hs-CRP > 1 showed lower HDL cholesterol (40 ± 2 mg/dl) and apo A1 (118 ± 4 mg/dl) than patients with hs-CRP ≤ 1 (50 ± 4 and 133 ± 5, respectively); p < 0.05. PON was lower in hs-CRP > 1 = 90.5 ± 24.0 µmol/ml.min than in hs-CRP ≤ 1 = 105.2 ± 18.0. Consequently, inverse correlations were obtained between apo A1 and hs-CRP, r = -0.381, p = 0.013 and between PON and hs-CRP, r = -0.32, p = 0.042. Furthermore, increase in hs-CRP correlated positively with BMI r = 0.318, p = 0.042. Since apo A1 has an anti-inflammatory role and PON an antioxidant activity, the decrease in HDL and its components, cholesterol, apo A1 and PON, in subjects with higher chronic inflammatory condition might explain, in part, the increased cardiovascular risk in these patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21163737

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN: 0025-7680            Impact factor:   0.653


  2 in total

1.  Serum C-reactive protein levels in pre-dialysis chronic kidney disease patientsin southern Nigeria.

Authors:  Oluseyi A Adejumo; Enajite I Okaka; Chimezie G Okwuonu; Ikponmwosa O Iyawe; Oluwole O Odujoko
Journal:  Ghana Med J       Date:  2016-03

2.  Serum paraoxonase 1 activity in patients with iron deficiency anemia.

Authors:  Yildiz Okuturlar; Asuman Gedikbasi; Nilgul Akalin; Meral Gunaldi; Deniz Yilmaz; Meral Mert; Ozlem Harmankaya; Aliye Soylu; Pinar Karakaya; Abdulbaki Kumbasar
Journal:  Arch Med Sci       Date:  2016-07-01       Impact factor: 3.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.